Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)

Nguyen Van Hiep, Wei Lun Sun, Po Hao Feng, Cheng Wei Lin, Kuan Yuan Chen, Ching Shan Luo, Le Ngoc Dung, Hoang Van Quyet, Sheng Ming Wu*, Kang Yun Lee*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.

Original languageEnglish
Article number1106553
JournalFrontiers in Oncology
Volume12
DOIs
StatePublished - 13 12 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Van Hiep, Sun, Feng, Lin, Chen, Luo, Dung, Van Quyet, Wu and Lee.

Keywords

  • bioinformatics
  • biomarker
  • heparin-binding EGF-like growth factor (HBEGF)
  • immune infiltration
  • macrophage chemotaxis
  • non-small cell lung cancer

Fingerprint

Dive into the research topics of 'Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)'. Together they form a unique fingerprint.

Cite this